NASDAQ NMS - GLOBAL MARKET · TXMD
-1.63% · -$0.0400 · Vol 8.0K
Market closed · last close 4:00 PM ET · price as of 16:51:46 ET
TherapeuticsMD Inc

TherapeuticsMD Inc

Pharmaceuticals
$2.14
Card
Relationship Map

Follow $TXMD

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $TXMD by email

Veridion Score

BETALOW CONF · 5 of 6 factors measuredMethodology
Sentiment absence reason unknown
TXMD
TherapeuticsMD Inc
Sat Sep 19 · market closed · Markets closed · resumes Mon 9:30 ET
Lowest range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

29/ 100
Veridion Score
Lowest range · LOW confidence · 5 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 5 of 6 factors measured · Sat Sep 19 · market closed · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is TXMD moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading TXMD catalysts
About TherapeuticsMD Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2002
Employees
1
Country
US

TherapeuticsMD Inc is a pharmaceutical royalty company that owns and manages intellectual property, including trademarks and product rights, which are licensed to third-party pharmaceutical companies. The company generates revenue mainly through royalties and milestone payments from licensed products, including IMVEXXY, BIJUVA, and ANNOVERA, and does not directly manufacture or market pharmaceutical products.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$2.19
Day high
$2.19
Day low
$2.18
Previous close
$2.18
52W high
$2.77
-22.58% from high
52W low
$1.04
64% of range
Market cap
$25.2M
P/E
26.80×
EPS
$0.0800
Beta
0.11
Shares out
11.6M
Volume
8K
0.27× rel vol
Avg volume
29.4K
VWAP
$2.18
Price history computed in-house
1W
-0.72%
1M
+4.10%
3M
+9.97%
1Y
+96.73%
YTD
+31.56%
SMA 50 $2.10 · above
SMA 200 $2.09 · above
52W position 64%

TXMD overview

Veridion Score
29
Registered · 2026-09-18
5 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around TXMD.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading TXMD Form 4 filings
Public disclosures

Congress activity in TXMD

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for TXMD in the cached public ledger.

Federal contracts

TXMD contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for TXMD in this window.
Lobbying spend

TXMD lobbying filings, year to date.

Registered lobbying filings matched to TherapeuticsMD Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for TXMD in this window.
Loading news for TXMD
Analyst ratings
Sovereign unlock shows live analyst consensus for TXMD.
Options
Sovereign unlock shows live options positioning for TXMD.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.